Determination of rofecoxib, a cyclooxygenase-2 specific inhibitor, in human plasma using high-performance liquid chromatography with post-column photochemical derivatization and fluorescence detection

スポンサーリンク

概要

• 論文の詳細を見る
• 1999-07-09

著者

• Matuszewski B.

  Department Of Drug Metabolism Merck Research Laboratories

• Woolf E.

  Department Of Drug Metabolism And Pharmacokinetics

• Fu I.

  Department Of Drug Metabolism Merck Research Laboratories

関連論文

• Determination of pilocarpic acid in human plasma by capillary gas chromatography with mass-selective detection
• Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid-liquid extraction and HPLC-MS/MS
• Determination of an investigational HIV integrase inhibitor in human plasma using high performance liquid chromatography with tandem mass spectrometric detection
• Determination of a cyclooxygenase II inhibitor in human plasma by capillary gas chromatography with mass spectrometric detection
• Determination of felodipine, its enantiomers, and a pyridine metabolite in human plasma by capillary gas chromatography with mass spectrometric detection
• Effect of disease state on ionization during bioanalysis of MK-7009, a selective HCV NS3/NS4 protease inhibitor, in human plasma and human Tween-treated urine by high-performance liquid chromatography with tandem mass spectrometric detection
• Determination of rofecoxib, a cyclooxygenase-2 specific inhibitor, in human plasma using high-performance liquid chromatography with post-column photochemical derivatization and fluorescence detection

スポンサーリンク